Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients

Diagnostic Microbiology and Infectious Disease

Volumn 43, Issue 3, 2002, Pages 183-188

  Suntharam, Nila ^a   Lankford, Mary G ^b   Trick, William E ^c   Peterson, Lance R ^a,b   Noskin, Gary A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ANUS; ARTICLE; BACTERIAL INFECTION; CARCINOMA; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RECTUM; RISK FACTOR; SAMPLING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; CHICAGO; ENTEROCOCCUS; FEMALE; HEMATOLOGY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0036069146     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00392-9     Document Type: Article

References (28)

1. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci
2. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage
3. Characterization of glycopeptide-resistant enterococci from U.S. hospitals
4. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
5. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile
6. Recommendations for preventing the spread of vancomycin resistance
7. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
8. Vancomycin-resistant enterococci in Brooklyn, New York: A moment in time
9. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
10. Outbreak of vancomycin-, ampicillin-, aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit
11. Infection-control measures to reduce transmission of vancomycin-resistant enterococci in an endemic setting
12. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center
13. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces
14. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
15. Persistent contamination of fabric covered furniture by vancomycin resistant enterococci: Implications for upholstery selection in hospitals
16. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: Risk factors for colonization
17. Vancomycin-resistant enterococci in intensive care units
18. Cephalosporins as risk factors for nosocomial Enterococcus faecalis bacteremia: A matched case-control study
19. Comparison of genomic methods for differentiating strains of Enterococcus faecium: Assessment using clinical epidemiologic data
20. Vancomycin-resistant-enterococci-colonization of 24 patients on a pediatric oncology ward
21. Vancomycin-resistant Enterococci faecium colonization in children
22. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?
23. Molecular epidemiology of vancomycin-resistant enterococci: A 2-year perspective
24. The prevalence of colonization with vancomycin-resistant enterococcus at a Veterans' Affairs institution
25. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci
26. Point prevalence survey of nosocomial pathogens at a tertiary care center